Click here to close now.

SYS-CON MEDIA Authors: Liz McMillan, AppDynamics Blog, David Sprott, tru welu, Blue Box Blog

News Feed Item

Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018

NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018

http://www.reportlinker.com/p02316118/Molecular-Biology-Enzymes-Kits--Reagents-Market-by-Application-Cloning-Epigenetics-PCR-Restriction-Digestion-Sequencing-Product-Ligase-Phosphatase-Polymerase-Protease-Restriction-Endonuclease-Reverse-Transcriptase-Global-Forecast-to-2018.html

The global molecular biology enzymes, kits and reagents market is segmented by application, end users, products, and geographies. Molecular biology enzymes, kits and reagents find applications in a large number of fields of life science research. The application segments included in this report are cloning, epigenetics, PCR (polymerase chain reaction), restriction digestion, sequencing, and other applications. The end-user segments of this market are academic research institutes, hospitals and diagnostics centers, pharmaceutical and biotech companies, and other end users.

The product segments included in this report are enzymes, and kits & reagents. The enzymes segment is divided into the ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptases, and other enzymes sub-segments. The ligase enzyme sub-segment is further divided into T4 DNA ligase, thermostable DNA ligase, and other ligases. The polymerase enzyme sub-segment is divided into high fidelity DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, and other polymerases, while the restriction endonuclease enzyme sub-segment is divided into BamHI, EcoRI, PstI, and other restriction endonucleases.

The kits and reagents product segment has five sub-segments, namely, cloning and mutagenesis, nucleic acid analysis, PCR sequencing, and other kits and reagents.

The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and U.S. RoW encompasses Latin America, Middle East and Africa, and the Pacific countries.

The key drivers for this market are the rising R&D expenditure by the pharmaceutical and biotech companies, and increasing public funding for life science research. The World Health Organization estimates that the total aged population may rise from 605 million in 2000 (11% of the global population) to 2 billion by 2050, accounting for 22% of the global population. As this segment of the world population is more susceptible to chronic diseases, research into these ailments will become more significant, driving the growth of the molecular biology enzymes, kits & reagents market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global molecular biology enzymes, kits and reagents market and its sub-segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their molecular biology enzymes, kits and reagents market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important sub-segments. It maps market sizes and growth rates of each sub-segment and identifies the segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the molecular biology enzymes, kits and reagents market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development/Innovation: Product portfolios of top players in the molecular biology enzymes, kits and reagents market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the molecular biology enzymes, kits and reagents market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the molecular biology enzymes, kits and reagents market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various molecular biology enzymes, kits and reagents products across geographies
- Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the molecular biology enzymes, kits and reagents market
TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKETS COVERED 22
1.3 STAKEHOLDERS 24
1.4 RESEARCH METHODOLOGY 25
1.4.1 SECONDARY RESEARCH 25
1.4.1.1 Key data from secondary sources 26
1.4.2 PRIMARY RESEARCH 27
1.4.2.1 Key data from primary sources 27
1.4.3 MARKET SIZE ESTIMATION METHODOLOGY 28
1.4.4 MARKET FORECAST 29
1.4.5 MARKET DATA VALIDATION AND DATA TRIANGULATION 30
1.5 ASSUMPTIONS 31
2 EXECUTIVE SUMMARY 32
3 MARKET OVERVIEW 37
3.1 INTRODUCTION 38
3.2 MARKET SEGMENTATION 38
3.3 MARKET DYNAMICS 40
3.3.1 MARKET DRIVERS 41
3.3.1.1 Increased funding in life science research to propel the growth of the molecular biology enzymes and kits & reagents market 41
3.3.1.2 Increased intensity of research activities in the pharmaceutical sector to drive the market 41
3.3.1.3 Growth in genomics and molecular diagnostics markets will aid the growth of the molecular biology enzymes and kits & reagents market 42
3.3.1.4 Increased healthcare spending will aid the growth of the molecular biology enzymes and kits & reagents market 42
3.3.1.5 Rapidly aging population and chronic and infectious diseases are expected to drive the molecular biology enzymes and kits & reagents market 43
3.3.2 MARKET RESTRAINTS 43
3.3.2.1 Stringent regulatory framework acts as a major challenge 43
3.3.2.2 High degree of consolidation would act as a high entry barrier for new entrants 44
3.3.3 MARKET OPPORTUNITIES 44
3.3.3.1 Increased use of personalized medicine 44
3.3.3.2 Developing countries present significant opportunities for the molecular biology enzymes and kits & reagents market 44
3.4 MARKET SHARE ANALYSIS 45
4 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION 48
4.1 INTRODUCTION 49
4.2 CLONING 52
4.3 EPIGENETICS 54
4.4 PCR 55
4.5 RESTRICTION DIGESTION 57
4.6 SEQUENCING 58
4.7 OTHER APPLICATIONS 60
5 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER 62
5.1 INTRODUCTION 63
5.2 ACADEMIC RESEARCH INSTITUTES 66
5.3 HOSPITALS AND DIAGNOSTICS CENTERS 68
5.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 69
5.5 OTHER END USERS 71
6 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
6.2 ENZYMES 76
6.2.1 LIGASES 81
6.2.2 PHOSPHATASES 82
6.2.3 POLYMERASES 83
6.2.4 PROTEASES AND PROTEINASES 86
6.2.5 RESTRICTION ENDONUCLEASES 87
6.2.6 REVERSE TRANSCRIPTASES 89
6.2.7 OTHER ENZYMES 91
6.3 KITS & REAGENTS 92
6.3.1 CLONING AND MUTAGENESIS 96
6.3.2 NUCLEIC ACID ANALYSIS 98
6.3.3 PCR 99
6.3.4 SEQUENCING 101
6.3.5 OTHER KITS AND REAGENTS 102
7 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY 104
7.1 INTRODUCTION 105
7.2 ASIA 108
7.2.1 CHINA 118
7.2.2 INDIA 125
7.2.3 JAPAN 131
7.2.4 REST OF ASIA (ROA) 138
7.3 EUROPE 145
7.3.1 FRANCE 154
7.3.2 GERMANY 160
7.3.3 ITALY 166
7.3.4 SPAIN 172
7.3.5 U.K. 179
7.3.6 REST OF EUROPE (ROE) 185
7.4 NORTH AMERICA 191
7.4.1 CANADA 200
7.4.2 U.S. 206
7.5 REST OF THE WORLD (ROW) 213
7.5.1 LATIN AMERICA 221
7.5.2 MIDDLE EAST AND AFRICA 227
7.5.3 PACIFIC 234
8 COMPETITIVE LANDSCAPE 240
8.1 INTRODUCTION 240
8.2 NEW PRODUCT LAUNCHES 241
8.3 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND JOINT VENTURES 247
8.4 EXPANSIONS 253
8.5 MERGERS AND ACQUISITIONS 255
8.6 OTHER DEVELOPMENTS 256
9 COMPANY PROFILES 259
9.1 AFFYMETRIX, INC. 259
9.2 AGILENT TECHNOLOGIES, INC. 266
9.3 ENZYMATICS, INC. 270
9.4 ILLUMINA, INC. 273
9.5 NEW ENGLAND BIOLABS, INC. 280
9.6 QIAGEN, N.V. 287
9.7 ROCHE, LTD. 291
9.8 SIGMA-ALDRICH CORPORATION 294
9.9 TAKARA BIO, INC. 298
9.10 THERMO FISHER SCIENTIFIC, INC. 303

*Details on Business Overview, Company Snapshot, Product Portfolio, Key Strategy, & Recent Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 52
TABLE 2 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR CLONING, BY GEOGRAPHY, 2011–2018 ($MILLION) 53
TABLE 3 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR EPIGENETICS, BY GEOGRAPHY,
2011–2018 ($MILLION) 55
TABLE 4 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR PCR, BY GEOGRAPHY, 2011–2018 ($MILLION) 56
TABLE 5 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR RESTRICTION DIGESTION, BY GEOGRAPHY,
2011–2018 ($MILLION) 58
TABLE 6 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR SEQUENCING, BY GEOGRAPHY,
2011–2018 ($MILLION) 59
TABLE 7 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR OTHER APPLICATIONS, BY GEOGRAPHY,
2011–2018 ($MILLION) 61
TABLE 8 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 66
TABLE 9 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY GEOGRAPHY, 2011–2018 ($MILLION) 67
TABLE 10 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS,
BY GEOGRAPHY, 2011–2018 ($MILLION) 68
TABLE 11 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2011–2018 ($MILLION) 70
TABLE 12 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE FOR OTHER END USERS, BY GEOGRAPHY,
2011–2018 ($MILLION) 71
TABLE 13 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 75
TABLE 14 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 79
TABLE 15 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY GEOGRAPHY, 2011–2018 ($MILLION) 80
TABLE 16 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR LIGASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 82
TABLE 17 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR PHOSPHATASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 83
TABLE 18 REPRESENTATIVE LIST FOR POLYMERASES PRODUCTS 84
TABLE 19 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR POLYMERASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 85
TABLE 20 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR PROTEASES AND PROTEINASES, BY GEOGRAPHY,
2011–2018 ($MILLION) 87
TABLE 21 RESTRICTION ENDONUCLEASES ENZYME: RECONGNITION SEQUENCE AND MAJOR SUPPLIERS 88
TABLE 22 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET FOR RESTRICTION ENDONUCLEASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 89
TABLE 23 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR REVERSE TRANSCRIPTASES, BY GEOGRAPHY, 2011–2018 ($MILLION) 90
TABLE 24 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE FOR OTHER ENZYMES, BY GEOGRAPHY, 2011–2018 ($MILLION) 91
TABLE 25 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 95
TABLE 26 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY GEOGRAPHY, 2011–2018 ($MILLION) 96
TABLE 27 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR CLONING AND MUTAGENESIS, BY GEOGRAPHY, 2011–2018 ($MILLION) 97
TABLE 28 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR NUCLEIC ACID ANALYSIS, BY GEOGRAPHY, 2011–2018 ($MILLION) 99
TABLE 29 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR PCR, BY GEOGRAPHY, 2011–2018 ($MILLION) 100
TABLE 30 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE FOR SEQUENCING, BY GEOGRAPHY, 2011–2018 ($MILLION) 102
TABLE 31 GLOBAL OTHER MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 103
TABLE 32 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 107
TABLE 33 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 112
TABLE 34 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 113
TABLE 35 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 114
TABLE 36 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 115
TABLE 37 ASIA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 116
TABLE 38 ASIA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 117
TABLE 39 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 120
TABLE 40 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 121
TABLE 41 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS, & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 122
TABLE 42 CHINA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 122
TABLE 43 CHINA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 124
TABLE 44 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 126
TABLE 45 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 127
TABLE 46 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 128
TABLE 47 INDIA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 128
TABLE 48 INDIA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 130
TABLE 49 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 133
TABLE 50 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 134
TABLE 51 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 135
TABLE 52 JAPAN: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 135
TABLE 53 JAPAN: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 137
TABLE 54 ROA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 140
TABLE 55 ROA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 141
TABLE 56 ROA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 142
TABLE 57 ROA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 142
TABLE 58 ROA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 144
TABLE 59 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2011–2018 ($MILLION) 148
TABLE 60 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 149
TABLE 61 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 150
TABLE 62 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 151
TABLE 63 EUROPE: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 151
TABLE 64 EUROPE: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 153
TABLE 65 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 155
TABLE 66 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 156
TABLE 67 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 157
TABLE 68 FRANCE: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 157
TABLE 69 FRANCE: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 159
TABLE 70 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 161
TABLE 71 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 162
TABLE 72 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 163
TABLE 73 GERMANY: MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 163
TABLE 74 GERMANY: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 165
TABLE 75 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 167
TABLE 76 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 168
TABLE 77 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 169
TABLE 78 ITALY: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 169
TABLE 79 ITALY: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 171
TABLE 80 SPAIN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 174
TABLE 81 SPAIN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 175
TABLE 82 SPAIN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 176
TABLE 83 SPAIN: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 177
TABLE 84 SPAIN: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 178
TABLE 85 U.K.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 180
TABLE 86 U.K.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 181
TABLE 87 U.K.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 182
TABLE 88 U.K.: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 182
TABLE 89 U.K.: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 184
TABLE 90 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 186
TABLE 91 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 187
TABLE 92 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 188
TABLE 93 ROE: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 188
TABLE 94 ROE: MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 190
TABLE 95 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 194
TABLE 96 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 195
TABLE 97 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 196
TABLE 98 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 197
TABLE 99 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 197
TABLE 100 NORTH AMERICA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 199
TABLE 101 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 201
TABLE 102 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 202
TABLE 103 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 203
TABLE 104 CANADA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 203
TABLE 105 CANADA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 205
TABLE 106 U.S.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 208
TABLE 107 U.S.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 209
TABLE 108 U.S.: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 210
TABLE 109 U.S.: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 210
TABLE 110 U.S.: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 212
TABLE 111 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2011–2018 ($MILLION) 216
TABLE 112 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 217
TABLE 113 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 218
TABLE 114 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 219
TABLE 115 ROW: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 219
TABLE 116 ROW: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 221
TABLE 117 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 223
TABLE 118 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 224
TABLE 119 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 225
TABLE 120 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 225
TABLE 121 LATIN AMERICA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 227
TABLE 122 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 229
TABLE 123 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 230
TABLE 124 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 231
TABLE 125 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 231
TABLE 126 MIDDLE EAST AND AFRICA: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 233
TABLE 127 PACIFIC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2011–2018 ($MILLION) 235
TABLE 128 PACIFIC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2011–2018 ($MILLION) 236
TABLE 129 PACIFIC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 237
TABLE 130 PACIFIC: MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2011–2018 ($MILLION) 237
TABLE 131 PACIFIC: MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2011–2018 ($MILLION) 239
TABLE 132 NEW PRODUCT LAUNCHES, 2011–2014 241
TABLE 133 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND
JOINT VENTURES, 2011–2014 248
TABLE 134 EXPANSIONS, 2011–2014 253
TABLE 135 MERGERS AND ACQUISITIONS, 2011–2014 255
TABLE 136 OTHER DEVELOPMENTS, 2011–2014 257
LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 25
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 28
FIGURE 3 MARKET FORECASTING MODEL 29
FIGURE 4 DATA TRIANGULATION METHODOLOGY 30
FIGURE 1 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2013 VS. 2018 ($MILLION) 32
FIGURE 2 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2013 VS. 2018 ($MILLION) 33
FIGURE 3 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2013 VS. 2018 ($MILLION) 34
FIGURE 4 GLOBAL MOLECULAR BIOLOGY KITS AND REAGENTS MARKET SIZE,
BY PRODUCT, 2013 VS. 2018 ($MILLION) 35
FIGURE 5 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 36
FIGURE 6 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION 39
FIGURE 7 MARKET DRIVERS AND RESTRAINTS 40
FIGURE 8 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 46
FIGURE 9 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION, BY APPLICATION 49
FIGURE 10 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2013 (MARKET SIZE AND GROWTH RATE) 50
FIGURE 11 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2013 VS. 2018 ($MILLION) 51
FIGURE 12 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION, BY END USER 63
FIGURE 13 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2013 (MARKET SIZE AND GROWTH RATES) 64
FIGURE 14 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY END USER, 2013 VS. 2018 ($MILLION) 65
FIGURE 15 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SEGMENTATION, BY PRODUCT 75
FIGURE 16 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET, BY PRODUCT,
2013 (MARKET SIZE AND GROWTH RATE) 77
FIGURE 17 GLOBAL MOLECULAR BIOLOGY ENZYMES MARKET SIZE, BY PRODUCT, 2013 VS. 2018 ($MILLION) 78
FIGURE 18 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET,
BY PRODUCT, 2013 (MARKET SIZE AND GROWTH RATE) 93
FIGURE 19 GLOBAL MOLECULAR BIOLOGY KITS & REAGENTS MARKET SIZE,
BY PRODUCT, 2013 VS. 2018 ($MILLION) 94
FIGURE 20 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY, 2013 (MARKET SIZE AND GROWTH RATE) 105
FIGURE 21 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 106
FIGURE 22 ASIA: ECONOMIC INDICATORS (2003–2012) 108
FIGURE 23 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY, 2013 (MARKET SIZE AND GROWTH RATE) 110
FIGURE 24 ASIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 111
FIGURE 25 CHINA: ECONOMIC INDICATORS (2003–2012) 118
FIGURE 26 INDIA: ECONOMIC INDICATORS (2003–2012) 125
FIGURE 27 JAPAN: ECONOMIC INDICATORS (2003–2012) 131
FIGURE 28 ROA: ECONOMIC INDICATORS (2003–2012) 138
FIGURE 29 EUROPE: ECONOMIC INDICATORS (2003–2012) 145
FIGURE 30 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY, 2013 (MARKET SIZE AND GROWTH RATE) 146
FIGURE 31 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 147
FIGURE 32 FRANCE: ECONOMIC INDICATORS (2003–2012) 154
FIGURE 33 GERMANY: ECONOMIC INDICATORS (2003–2012) 160
FIGURE 34 ITALY: ECONOMIC INDICATORS (2003–2012) 166
FIGURE 35 SPAIN: ECONOMIC INDICATORS (2003–2012) 172
FIGURE 36 U.K.: ECONOMIC INDICATORS (2003–2012) 179
FIGURE 37 ROE: ECONOMIC INDICATORS (2003–2012) 185
FIGURE 38 NORTH AMERICA: ECONOMIC INDICATORS (2003–2012) 191
FIGURE 39 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2013 (MARKET SIZE AND GROWTH RATE) 192
FIGURE 40 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2013 VS. 2018 ($MILLION) 193
FIGURE 41 CANADA: ECONOMIC INDICATORS (2003–2012) 200
FIGURE 42 U.S.: ECONOMIC INDICATORS (2003–2012) 206
FIGURE 43 ROW: ECONOMIC INDICATORS (2003–2012) 213
FIGURE 44 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY REGION, 2013 (MARKET SIZE AND GROWTH RATE) 214
FIGURE 45 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE, BY REGION, 2013 VS. 2018 ($MILLION) 215
FIGURE 46 LATIN AMERICA: ECONOMIC INDICATORS (2003–2012) 222
FIGURE 47 MIDDLE EAST AND AFRICA: ECONOMIC INDICATORS (2003–2012) 228
FIGURE 48 PACIFIC: ECONOMIC INDICATORS (2003–2012) 234
FIGURE 49 KEY GROWTH STRATEGIES FOR THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, 2011–2014 240


To order this report: Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018
http://www.reportlinker.com/p02316118/Molecular-Biology-Enzymes-Kits--Reagents-Market-by-Application-Cloning-Epigenetics-PCR-Restriction-Digestion-Sequencing-Product-Ligase-Phosphatase-Polymerase-Protease-Restriction-Endonuclease-Reverse-Transcriptase-Global-Forecast-to-2018.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The most often asked question post-DevOps introduction is: “How do I get started?” There’s plenty of information on why DevOps is valid and important, but many managers still struggle with simple basics for how to initiate a DevOps program in their business. They struggle with issues related to current organizational inertia, the lack of experience on Continuous Integration/Delivery, understanding where DevOps will affect revenue and budget, etc. In their session at DevOps Summit, JP Morgentha...
In a recent research, analyst firm IDC found that the average cost of a critical application failure is $500,000 to $1 million per hour and the average total cost of unplanned application downtime is $1.25 billion to $2.5 billion per year for Fortune 1000 companies. In addition to the findings on the cost of the downtime, the research also highlighted best practices for development, testing, application support, infrastructure, and operations teams.
The speed of product development has increased massively in the past 10 years. At the same time our formal secure development and SDL methodologies have fallen behind. This forces product developers to choose between rapid release times and security. In his session at DevOps Summit, Michael Murray, Director of Cyber Security Consulting and Assessment at GE Healthcare, examined the problems and presented some solutions for moving security into the DevOps lifecycle to ensure that we get fast AND ...
SYS-CON Events announced today that MetraTech, now part of Ericsson, has been named “Silver Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York, NY. Ericsson is the driving force behind the Networked Society- a world leader in communications infrastructure, software and services. Some 40% of the world’s mobile traffic runs through networks Ericsson has supplied, serving more than 2.5 billion subscribers.
The OpenStack cloud operating system includes Trove, a database abstraction layer. Rather than applications connecting directly to a specific type of database, they connect to Trove, which in turn connects to one or more specific databases. One target database is Postgres Plus Cloud Database, which includes its own RESTful API. Trove was originally developed around MySQL, whose interfaces are significantly less complicated than those of the Postgres cloud database. In his session at 16th Cloud...
How does one bridge the gap between traditional enterprise storage infrastructures and the private, hybrid, and public cloud? In his session at 15th Cloud Expo, Dan Pollack, Chief Architect of Storage Operations at AOL Inc., examed the workload differences and required changes to reuse existing knowledge and components when building and using a cloud infrastructure. He also looked into the operational considerations, tool requirements, and behavioral changes required for private cloud storage s...
Software is eating the world. Companies that were not previously in the technology space now find themselves competing with Google and Amazon on speed of innovation. As the innovation cycle accelerates, companies must embrace rapid and constant change to both applications and their infrastructure, and find a way to deliver speed and agility of development without sacrificing reliability or efficiency of operations. In her Day 2 Keynote DevOps Summit, Victoria Livschitz, CEO of Qubell, discussed...
In their general session at 16th Cloud Expo, Michael Piccininni, Global Account Manager – Cloud SP at EMC Corporation, and Mike Dietze, Regional Director at Windstream Hosted Solutions, will review next generation cloud services, including the Windstream-EMC Tier Storage solutions, and discuss how to increase efficiencies, improve service delivery and enhance corporate cloud solution development. Speaker Bios Michael Piccininni is Global Account Manager – Cloud SP at EMC Corporation. He has b...
Explosive growth in connected devices. Enormous amounts of data for collection and analysis. Critical use of data for split-second decision making and actionable information. All three are factors in making the Internet of Things a reality. Yet, any one factor would have an IT organization pondering its infrastructure strategy. How should your organization enhance its IT framework to enable an Internet of Things implementation? In this session, James Kirkland, Red Hat's Chief Architect for the ...
Working with Big Data is challenging, especially when decision makers depend on market insights and intelligence from your data but don't have quick access to it or find it unusable. In their session at 6th Big Data Expo, Ian Khan, Global Strategic Positioning & Brand Manager at Solgenia; Zel Bianco, President, CEO and Co-Founder of Interactive Edge of Solgenia; and Ermanno Bonifazi, CEO & Founder at Solgenia, discussed how a revolutionary cloud-based BI along with mobile analytics is already c...
While there are hundreds of public and private cloud hosting providers to choose from, not all clouds are created equal. If you’re seeking to host enterprise-level mission-critical applications, where Cloud Security is a primary concern, WHOA.com is setting new standards for cloud hosting, and has established itself as a major contender in the marketplace. We are constantly seeking ways to innovate and leverage state-of-the-art technologies. In his session at 16th Cloud Expo, Mike Rivera, Seni...
Hardware will never be more valuable than on the day it hits your loading dock. Each day new servers are not deployed to production the business is losing money. While Moore's Law is typically cited to explain the exponential density growth of chips, a critical consequence of this is rapid depreciation of servers. The hardware for clustered systems (e.g., Hadoop, OpenStack) tends to be significant capital expenses. In his session at Big Data Expo, Mason Katz, CTO and co-founder of StackIQ, disc...
There is no question that the cloud is where businesses want to host data. Until recently hypervisor virtualization was the most widely used method in cloud computing. Recently virtual containers have been gaining in popularity, and for good reason. In the debate between virtual machines and containers, the latter have been seen as the new kid on the block – and like other emerging technology have had some initial shortcomings. However, the container space has evolved drastically since coming on...
The 4th International Internet of @ThingsExpo, co-located with the 17th International Cloud Expo - to be held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA - announces that its Call for Papers is open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
T-Mobile has been transforming the wireless industry with its “Uncarrier” initiatives. Today as T-Mobile’s IT organization works to transform itself in a like manner, technical foundations built over the last couple of years are now key to their drive for more Agile delivery practices. In his session at DevOps Summit, Martin Krienke, Sr Development Manager at T-Mobile, will discuss where they started their Continuous Delivery journey, where they are today, and where they are going in an effort ...